Brief: ABVC Biopharma - Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon
03/03/2026 21:52
March 3 (Reuters) - ABVC Biopharma Inc ABVC.O: ABVC BIOPHARMA - QTRLY PERIOD ENDED SEPTEMBER, 2025 FINANCIAL STATEMENTS SHOULD NOT BE RELIED UPON ABVC BIOPHARMA INC - REPORTS MATERIAL WEAKNESS IN INTERNAL CONTROLS OVER FINANCIAL REPORTING FOR FY2025 - SEC FILING Further company coverage: ABVC.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on ABVC Biopharma
See all newsBrief: ABVC Biopharma Says Biokey Share Distribution Rescheduled For August 21
NASDAQ RESUMED AT 09:05 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 04:43 PM
Brief: ABVC Biopharma - Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon